Inventor · disambiguated record
Qi Huang
Also filed as: HUANG QI
25 granted patents·15 pending applications·387 citations·filing 2000–2022
96Inventor score
Files withAMGEN INC16WISYS TECHNOLOGY FOUND INC4HENRIKSSON MARTIN2NG GORDON2BEIJING PHARSCIN INNOBIO CO LTD1
Top patents by PatentIndex Score
40 records- 0195US6878714B2Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2002·Granted Apr 12, 2005·85 cites·39 claims
- 0292US6995162B2Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2002·Granted Feb 7, 2006·48 cites·26 claims
- 0391US7253196B2Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1BIOVITRUM AB·Filed 2005·Granted Aug 7, 2007·19 cites·15 claims
- 0491US7102009B2Substituted amine derivatives and methods of useAMGEN INC·Filed 2002·Granted Sep 5, 2006·49 cites·20 claims
- 0590US7514564B2Substituted amine derivatives and methods of useAMGEN INC·Filed 2006·Granted Apr 7, 2009·16 cites·15 claims
- 0688US7807700B2Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1AMGEN INC·Filed 2007·Granted Oct 5, 2010·12 cites·16 claims
- 0787US8557830B2RAF kinase modulators and methods of useSMITH ADRIAN L·Filed 2008·Granted Oct 15, 2013·10 cites·13 claims
- 0887US7105682B2Substituted amine derivatives and methods of useAMGEN INC·Filed 2002·Granted Sep 12, 2006·29 cites·17 claims
- 0986US8642624B2Substituted alkylamine derivatives and methods of useCHEN GUOQING·Filed 2011·Granted Feb 4, 2014·11 cites·3 claims
- 1085USRE47475ESelective agents for pain suppressionWISYS TECH FOUNDATION INC·Filed 2016·Granted Jul 2, 2019·4 cites·15 claims
- 1185US7101868B2Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2004·Granted Sep 5, 2006·20 cites·36 claims
- 1284US7307088B2Substituted anthranilic amide derivatives and methods of useAMGEN INC·Filed 2003·Granted Dec 11, 2007·24 cites·18 claims
- 1382US7235656B2Anxiolytic agents with reduced sedative and ataxic effectsWISYS TECHNOLOGY FOUND INC·Filed 2006·Granted Jun 26, 2007·5 cites·8 claims
- 1482US6849639B2Integrin inhibitors and their methods of useAMGEN INC·Filed 2000·Granted Feb 1, 2005·19 cites·8 claims
- 1579US7119196B2Anxiolytic agents with reduced sedative and ataxic effectsWISYS TECHNOLOGY FOUND INC·Filed 2003·Granted Oct 10, 2006·12 cites·5 claims
- 1677US7119111B22-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of useAMGEN INC·Filed 2003·Granted Oct 10, 2006·11 cites·24 claims
- 1774US8541592B2Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1HENRIKSSON MARTIN·Filed 2006·Granted Sep 24, 2013·3 cites·11 claims
- 1873US8440674B2Substituted pyrimidine compounds as RAF inhibitors and methods of useDE MORIN FRENEL F·Filed 2011·Granted May 14, 2013·4 cites·12 claims
- 1972US8686011B2Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1HENRIKSSON MARTIN·Filed 2011·Granted Apr 1, 2014·3 cites·5 claims
- 2072US2009048149A1Antagonists of the bradykinin B1 receptorAMGEN INC·Filed 2008·Application pending·0 cites
- 2171US8722896B2Prokineticin receptor antagonists and uses thereofZHOU QUN-YONG·Filed 2009·Granted May 13, 2014·2 cites·12 claims
- 2270US7662811B21,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of useAMGEN INC·Filed 2005·Granted Feb 16, 2010·1 cites·13 claims
- 2365US8288351B2Antagonists of the bradykinin B1 receptorNG GORDON·Filed 2008·Granted Oct 16, 2012·0 cites·14 claims
- 2465US8278280B2Antagonists of the bradykinin B1 receptorNG GORDON·Filed 2008·Granted Oct 2, 2012·0 cites·14 claims
- 2562US2008108605A1Anxiolytic agents with reduced sedative and ataxic effectsWISYS TECHNOLOGY FOUND INC·Filed 2007·Application pending·0 cites
- 2661US2007299058A1Anxiolytic Agents With Reduced Sedative And Ataxic EffectsWISYS TECHNOLOGY FOUND INC·Filed 2007·Application pending·0 cites
- 2758US2013273004A1Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2013·Application pending·0 cites
- 2857US2014005198A1Raf kinase modulators and methods of useAMGEN INC·Filed 2013·Application pending·0 cites
- 2957US2005153960A1Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2004·Application pending·0 cites
- 3055US2024391881A1Pharmaceutical use and preparation method for substituted heteroaryl phthalazine derivativeORIGIANT PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 3153US9723838B2Pyrazolyl amide compounds and uses thereofSHENYANG SINOCHEM AGROCHEMICALS R & D CO LTD·Filed 2014·Granted Aug 8, 2017·0 cites·4 claims
- 3253US2025186456A1Pyrimidine-fused cyclic compound and preparation method and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 3353US2024327386A1Ahr inhibitor, use thereof, and preparation method thereforBEIJING PHARSCIN INNOBIO CO LTD·Filed 2022·Application pending·0 cites
- 3452US2010130481A1Anticonvulsant and anxiolytic methods of using receptor subtype selective agentsCOOK JAMES M·Filed 2010·Application pending·0 cites
- 3548US2011082107A1Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1AMGEN INC·Filed 2010·Application pending·0 cites
- 3645US2024150387A1Glucocerebroside compound, pharmaceutical composition thereof and use thereofDONGGUAN HEC CORDYCEPS R&D CO LTD·Filed 2021·Application pending·0 cites
- 3743US2023167140A1Inositol derivative and use thereofSHANGHAI SENHUI MEDICINE CO LTD·Filed 2021·Application pending·0 cites
- 3841US2002147198A1Substituted arylamine derivatives and methods of useFiled 2002·Application pending·0 cites
- 3937US2015321164A1Method for synthesizing and screening lead compound and reagent testing kitHITGEN LTD·Filed 2013·Application pending·0 cites
- 4031US10196359B22-alkyloxy benzene formyl arylamine compound and pharmaceutical use thereofUNIV FUDAN·Filed 2015·Granted Feb 5, 2019·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Qi Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →